BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22173916)

  • 1. Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice.
    Sun X; Tang Y; Tan X; Li Q; Zhong W; Sun X; Jia W; McClain CJ; Zhou Z
    Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G548-57. PubMed ID: 22173916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.
    Shen Z; Liang X; Rogers CQ; Rideout D; You M
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G364-74. PubMed ID: 20007851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary α-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice.
    Wang M; Zhang XJ; Feng K; He C; Li P; Hu YJ; Su H; Wan JB
    Sci Rep; 2016 May; 6():26826. PubMed ID: 27220557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin deficiency contributes to the pathogenesis of alcoholic fatty liver disease in mice.
    Tan X; Sun X; Li Q; Zhao Y; Zhong W; Sun X; Jia W; McClain CJ; Zhou Z
    Am J Pathol; 2012 Oct; 181(4):1279-86. PubMed ID: 22841822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.
    Kang X; Zhong W; Liu J; Song Z; McClain CJ; Kang YJ; Zhou Z
    Hepatology; 2009 Oct; 50(4):1241-50. PubMed ID: 19637192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin regulates adipose tissue metabolism: Role in hepatic steatosis.
    Rasineni K; Kubik JL; Knight KL; Hall L; Casey CA; Kharbanda KK
    Chem Biol Interact; 2020 May; 322():109059. PubMed ID: 32171850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ agonist rosiglitazone switches fuel preference to lipids in promoting thermogenesis under cold exposure in C57BL/6 mice.
    Gao R; Chen W; Yan H; Xie X; Liu D; Wu C; Zhu Z; Li H; Dong F; Wang L
    J Proteomics; 2018 Mar; 176():24-36. PubMed ID: 29414316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone.
    Stechschulte LA; Qiu B; Warrier M; Hinds TD; Zhang M; Gu H; Xu Y; Khuder SS; Russo L; Najjar SM; Lecka-Czernik B; Yong W; Sanchez ER
    Endocrinology; 2016 Oct; 157(10):3888-3900. PubMed ID: 27442117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice.
    Duan SZ; Usher MG; Foley EL; Milstone DS; Brosius FC; Mortensen RM
    Diabetologia; 2010 Jul; 53(7):1493-505. PubMed ID: 20401461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.
    Tsuchida A; Yamauchi T; Takekawa S; Hada Y; Ito Y; Maki T; Kadowaki T
    Diabetes; 2005 Dec; 54(12):3358-70. PubMed ID: 16306350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.
    Li J; Xue YM; Zhu B; Pan YH; Zhang Y; Wang C; Li Y
    J Diabetes Res; 2018; 2018():4627842. PubMed ID: 30225267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion.
    Blanchard PG; Festuccia WT; Houde VP; St-Pierre P; Brûlé S; Turcotte V; Côté M; Bellmann K; Marette A; Deshaies Y
    J Lipid Res; 2012 Jun; 53(6):1117-25. PubMed ID: 22467681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated regulation of scopoletin at adipose tissue-liver axis improved alcohol-induced lipid dysmetabolism and inflammation in rats.
    Lee HI; Lee MK
    Toxicol Lett; 2015 Sep; 237(3):210-8. PubMed ID: 26115886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytes.
    Takazawa T; Yamauchi T; Tsuchida A; Takata M; Hada Y; Iwabu M; Okada-Iwabu M; Ueki K; Kadowaki T
    J Biol Chem; 2009 Oct; 284(44):30049-57. PubMed ID: 19706614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling.
    Wei X; Shi X; Zhong W; Zhao Y; Tang Y; Sun W; Yin X; Bogdanov B; Kim S; McClain C; Zhou Z; Zhang X
    PLoS One; 2013; 8(2):e55382. PubMed ID: 23405143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats.
    Ferrer-Lorente R; Cabot C; Fernández-López JA; Alemany M
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):339-48. PubMed ID: 20195573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Outcomes of Rosiglitazone Treatment on Fatty Liver.
    Gao M; Ma Y; Alsaggar M; Liu D
    AAPS J; 2016 Jul; 18(4):1023-31. PubMed ID: 27125895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.